SKYE LIFE LTD
Company number SC709187 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
SKYE LIFE LTD - Analysis Report
Company Number: SC709187
Analysis Date: 2025-07-29 18:58 UTC
Financial Health Assessment for SKYE LIFE LTD
1. Financial Health Score: B
Explanation:
SKYE LIFE LTD shows a solid improvement trajectory with increasing net assets and positive working capital. The company maintains a healthy cash position relative to current liabilities, indicating good short-term liquidity. However, the presence of long-term director's loans and relatively modest fixed assets suggests some leverage and reliance on internal financing. Overall, the company’s financial health is sound but could benefit from reducing long-term liabilities and expanding its asset base to strengthen resilience.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Cash at Bank | 43,817 | Healthy cash reserves to cover immediate expenses and short-term liabilities. |
| Current Liabilities | 7,905 | Relatively low short-term debts, manageable with available cash and assets. |
| Net Current Assets (Working Capital) | 35,912 | Positive working capital indicates strong short-term financial health and operational liquidity. |
| Total Assets Less Current Liabilities | 61,013 | Shows total resources available after settling short-term debts. |
| Long-term Liabilities (Director’s Loan) | 8,668 | Moderate long-term debt owed to directors, which may need managing to avoid cash flow strain. |
| Net Assets (Equity) | 52,345 | Significant growth from prior years, reflecting accumulated profits and retained earnings. |
| Fixed Assets (Net Book Value) | 25,101 | Investment in tangible assets increasing, supports operational capacity and business stability. |
3. Diagnosis: What the Financial Data Reveals
Symptom of Growth: Over the past years, net assets increased from just £42 in 2021 to £52,345 in 2024, showing the company is building equity and retaining profits rather than incurring losses. This is a strong positive sign, akin to a patient recovering and gaining strength.
Healthy Cash Flow Indicators: Cash levels have risen from £10,241 in 2021 to £43,817 in 2024, indicating good liquidity and ability to meet short-term obligations without distress.
Working Capital Comfort: The company’s current assets comfortably exceed current liabilities, meaning day-to-day operations are well-funded, reducing risk of liquidity crunch.
Long-term Liability as a Concern: The director’s loan account is significant (£8,668), though reduced from £28,151 last year, indicating some reliance on internal financing that should be monitored to prevent strain on future cash flows.
Asset Base and Investment: Tangible fixed assets increased, suggesting reinvestment into the business, which is a healthy sign of growth and sustainability.
Company Structure and Controls: With two significant shareholders holding 25-50% each and rights to appoint/remove directors, governance appears stable, minimizing risk of control disputes.
4. Recommendations: Steps to Improve Financial Wellness
Manage Long-term Debt: Develop a plan to reduce reliance on director’s loan accounts gradually, possibly by formalizing repayment schedules or replacing internal financing with external options if appropriate.
Enhance Profitability and Cash Generation: Continue focusing on operational efficiency and revenue growth to maintain positive cash flow and enable further asset investment.
Build Reserves for Contingencies: Aim to increase cash reserves beyond immediate liabilities to buffer against market fluctuations or unforeseen expenses, enhancing financial resilience.
Monitor Receivables and Payables: Although not explicitly detailed here, ensure effective credit control to maintain working capital health and avoid liquidity issues.
Prepare for Growth: Consider strategic investments in marketing or technology to expand online retail sales (SIC 47910) in a competitive sector.
Regular Financial Review: Maintain timely and accurate financial reporting to detect any early symptoms of distress and enable proactive management interventions.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.